BIOSCEPTRE INTERNATIONAL LTD has a total of 18 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, Canada and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GILL PARKASH, GOETSCH LILIANE and SHANGHAI ZHANGJIANG BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | Canada | 3 | |
#3 | Brazil | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 | |
#6 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Barden Julian Alexander | 16 |
#2 | Gidley-Baird Angus | 14 |
#3 | Angus Gidley-Baird | 2 |
#4 | Pilkington Glenn Ronald | 2 |
#5 | Julian Alexander Barden | 2 |
#6 | Gidley-Baird Augus | 1 |
#7 | Glenn Ronald Pilkington | 1 |
#8 | Grant Steven | 1 |
#9 | Brewis Neil | 1 |
#10 | Jones Philip | 1 |
Publication | Filing date | Title |
---|---|---|
AU2013238152A1 | Purinergic (P2X) receptors in extra-cellular body fluid | |
EP3395832A1 | Anti p2x7 receptor antibodies and fragments thereof | |
CA2729868A1 | Anti- p2x7 peptides and epitopes | |
AU2008299593A1 | Novel P2X7 epitopes | |
AU2007306924A1 | Hybridomas producing antibodies against non functional P2X7 receptor |